Adenosine receptor antagonist 1
Ac-RYYRIK-NH2
3,5,7-Trihydroxychromone 3-O-β-D-xylopyranoside
Fluoroclebopride
FC 131
Maresin 1
Cotadutide acetate
GLP-1 receptor agonist 2
5(Z),11(Z),14(Z)-Eicosatrienoic Acid
(±)18-HEPE
GLP-1R modulator C16
SR2640 hydrochloride
CYM50308
IMMH001
A6770
9,12-Octadecadiynoic Acid
Inotilone
DREADD agonist 21
ML352
Gap19
Pomalidomide-PEG6-butyl iodide
Tiotropium Bromide hydrate
Scopolamine hydrobromide trihydrate
Chrysosplenol D
Chrysosplenol C
Oxomemazine
VU0155041 sodium
MFZ 10-7 hydrochloride
mGluR2 modulator 2
Phyllomedusin
[D-Trp34]-Neuropeptide Y TFA
JNJ-5207787
β-Endorphin,human
[Ala11,D-Leu15]-Orexin B(human)
PSB 0474
MRS2179 tetrasodium hydrate
MRS2279
L-902688
Laropiprant sodium
KRAS inhibitor-13
SAH-SOS1A
KRAS G12C inhibitor 50
Pasireotide(diaspartate)
d[Cha4]-AVP TFA
L-NIL hydrochloride
STING-IN-5
AXC-715 hydrochloride
Monophosphoryl lipid A
MAPK-IN-1
Varenicline Tartrate
SSR180711 hydrochloride
Spinosyn A
GW791343 dihydrochloride
Naminidil
Remacemide hydrochloride
SB-366791
AP-18
Chembridge-5861528
PF-04745637
Pyr3